PIQ — Proteomics International Laboratories Share News
0.000.00%
- AU$19.82m
- AU$16.40m
- AU$3.37m
Australia Stock Exchange release from PROTEOMICS INTER : PRE_NR Ends: 08:22:52
Australia Stock Exchange release from PROTEOMICS INTER : Initial Directors' Interest Notices
Australia Stock Exchange release from PROTEOMICS INTER : Proposed issue of securities - PIQ
Australia Stock Exchange release from PROTEOMICS INTER : Director appointments
Australia Stock Exchange release from PROTEOMICS INTER : PromarkerD outperforms standard of care tests for DKD
Australia Stock Exchange release from PROTEOMICS INTER : PRE_NR Ends: 08:33:11
Australia Stock Exchange release from PROTEOMICS INTER : Change of Directors' Interest Notices
Australia Stock Exchange release from PROTEOMICS INTER : Exercise of Director Options
Australia Stock Exchange release from PROTEOMICS INTER : Application for quotation of securities - PIQ
Australia Stock Exchange release from PROTEOMICS INTER : Proteomics awarded $100,000 manufacturing funding
Australia Stock Exchange release from PROTEOMICS INTER : PRE_NR Ends: 08:22:54
Australia Stock Exchange release from PROTEOMICS INTER : Jobkeeper Payments Notification
Australia Stock Exchange release from PROTEOMICS INTER : PRE_NR Ends: 08:21:00
Australia Stock Exchange release from PROTEOMICS INTER : September 2021 Quarterly Activities Report and Appendix 4C
Australia Stock Exchange release from PROTEOMICS INTER : Notice of Annual General Meeting/Proxy Form
Australia Stock Exchange release from PROTEOMICS INTER : Proteomics Chairman Terry Sweet to retire at 2021 AGM
Australia Stock Exchange release from PROTEOMICS INTER : Clinical utility study shows benefit of PromarkerD testing
Australia Stock Exchange release from PROTEOMICS INTER : PRE_NR Ends: 09:39:44
Australia Stock Exchange release from PROTEOMICS INTER : Annual Report to shareholders